Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Budesonide Market?
In recent times, there has been a significant expansion in the market size of budesonide. It is projected to rise from $9.72 billion in 2024 to $10.36 billion in 2025, marking a compound annual growth rate (CAGR) of 6.6%. This robust growth during the historical period can be traced back to factors such as the increasing incidence of respiratory ailments, heightened awareness about inhaled corticosteroids, the unveiling of combination therapies involving budesonide, the development of healthcare infrastructure and accessibility, and the approval of budesonide for unofficial use in managing inflammatory bowel diseases.
What Growth Rate Is Forecasted for the Budesonide Market by 2029?
The market for budesonide is anticipated to witness considerable expansion in the next few years, escalating to $13.25 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. The growth in this forecast period is a result of the increasing need for effective medicinal solutions, advent of innovative drug delivery mechanisms, elevated use of budesonide, growing older population susceptible to asthma, and broadening of the generic budesonide product range. Noteworthy trends during this projected period incorporate the embrace of biologics and biosimilars, progress in medicinal delivery systems, validation of fresh formulations, creation of groundbreaking drug delivery methods, and advancements in technology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp
Which Key Companies Are Shaping the Future of the Budesonide Market?
Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.
Which Factors Are Driving Demand in the Budesonide Industry?
The rising prevalence of respiratory illnesses is predicted to fuel the expansion of the budesonide market. Respiratory conditions are medical disorders that impact the organs and tissues responsible for gas exchange in animals that breathe air. This surge in respiratory conditions is connected to growing air pollution, specifically contact with particulate matter and allergens, which greatly influences the incidence of asthma and chronic obstructive lung disease. Budesonide is employed in treating respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) to diminish inflammation, enhance airflow, and avert symptoms like wheezing and breathlessness. For example, in May 2024, the National Center for Health Statistics (NCHS), a health statistics institution in the US, reported that the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Moreover, the occurrence of asthma episodes in the preceding 12 months for adults within the same age range increased from 3.3% in 2021 to 3.7% in 2022. Consequently, the rising prevalence of respiratory diseases will stimulate the growth of the budesonide market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21121&type=smp
How Is the Budesonide Market Segmented by Several Divisions?
The budesonide market covered in this report is segmented –
1) By Type: Inhalation Powder, Aerosols, Injectable Suspension, Tablets And Capsules
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications
Subsegments:
1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)
2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers
3) By Injectable Suspension: Pre-filled Syringes, Vials
4) By Tablets And Capsules: Oral Tablets, Oral Capsules
What are the Emerging Market Trends Driving the Growth of the Budesonide Industry?
Significant businesses within the budesonide market are channeling their energy towards advancements in respiratory treatments, including oral therapy, with intentions to improve the convenience for the patient, enforce better adherence to treatment, and widen the selection of therapeutic options for managing asthma and other respiratory related issues. Oral budesonide therapy is an administered treatment taken orally, used predominantly to combat inflammatory conditions. As a case in point, Takeda Pharmaceuticals, a pharmaceutical business based in Japan, declared in February 2024 that the US Federal agency, the Food and Drug Administration (FDA), granted approval for EOHILIA, a budesonide oral suspension. This marked EOHILIA as the first and sole oral medication sanctioned by the FDA, aimed for patients aged 11 and older diagnosed with eosinophilic esophagitis (EoE). Following this, the FDA also sanctioned EOHILIA 2 mg to be taken twice daily, based on efficacy and safety results from a pair of multicenter, randomized, double-blind, placebo-controlled 12-week studies involving individuals aged 11 to 56 suffering from EoE.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report
Which Regions Are Driving Growth in the Budesonide Market?
North America was the largest region in the budesonide market in 2024. The regions covered in the budesonide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21121
This Report Delivers Insight On:
1. How big is the budesonide market, and how is it changing globally?
2. Who are the major companies in the budesonide market, and how are they performing?
3. What are the key opportunities and risks in the budesonide market right now?
4. Which products or customer segments are growing the most in the budesonide market?
5. What factors are helping or slowing down the growth of the budesonide market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model